![]() | Only 14 pages are availabe for public view |
Abstract This is a case control study. This work was carried out on samples collected from Ain Shams University from women attending outpatient clinics of Maternity Hospital (ASUMH) for Recurrent Early Pregnancy loss (REPL). All included women were admitted to outpatient clinic between 8-14 weeks gestation for termination of pregnancy due to absence of fetal cardiac activity or absence of fetal pole on ultrasonographic examination with history of two or more consecutive unexplained first trimestric miscarriage with no live birth. - Samples: (A) Study group (Case study), was compiled 60 samples were divided into Thirty placenta and Thirty urine samples from the same woman attending outpatient clinics of ASUMH for REPL. (B) Control study, was compiled 60 samples were divided into Thirty placenta and Thirty urine samples from women presented with first missed miscarriage with no history of recurrent early pregnancy loss and had at least one previous uneventful pregnancy with no previous obstetric history of adverse pregnancy outcomes. All the patients included in this study were subjected to the following: 1. DNA extraction from Placental and urine samples. 2. Detection of HPV by conventional PCR. 3. Detection of HPV by nested PCR. 4. Detection of HPV by SYBER green Real time PCR. 5. Genotyping of HPV by multiplex PCR. -The results indicated that: HPV infection was found as 16.6% and 26.7% in placental samples, 6.6% and 36.7% in urine samples by using PCR and nPCR or real-time PCR respectively. HPV- 16 was the predominance HPV type in both sample (10%) followed by HPV-31(6.6%) in both samples and HPVtypes 51 and 18 (3.3%) in both samples. There was 3.3% co infection (infection by more than one type of HPV) in placenta and urine samples by types 16 and 51. There was poor agreement of placenta and urine samples results in generic and a moderate agreement for type-specific detection of HPV. The results also showed a significantly difference between number of miscarriage in HPV positive (3.38±0.744) and HPV negative (2.95±0.385) placenta samples. |